Loading provider…
Loading provider…
Interventional Cardiology Physician in New Haven, CT
NPI: 1447248117Primary Practice Location
YALE-NEW HAVEN HOSPITAL
35 Park St, New Haven, CT
Primary Employer
Yale Medicine
yalemedicine.org
HQ Phone
Get MD Hari's Phone Numberphone_androidMobile
Get MD Hari's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCT State Medical License
Jacobi Medical Center
Residency • Internal Medicine
1993 - 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 96 | 199 |
| 2 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 68 | 70 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 48 | 92 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 45 | 61 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 40 | 69 |
Twenty-five years without progress: The enduring challenge of soft tissue sarcomas.
Authors: Philippos Apolinario Costa, Kelly Olino, Jonathan Trent
Journal: Cancer
Targeted therapy for thyroid cancer: An updated review of investigational agents.
Authors: Julie Sosa
Journal: Curr Opin Investig Drugs
Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.
Authors: Indukala Doddamane, Michael Digiovanna, Masoud Azodi, Maysa Abu-Khalaf
Publication Date: 2014-11-10
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Paclitaxel, PROCEDURE: Computed Tomography, DRUG: Cabozantinib S-malate, PROCEDURE: FDG-Positron Emission Tomography
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI), Daiichi Sankyo
Intervention / Treatment: DRUG: efatutazone
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, DRUG: Trametinib